Influence of CFH, HTRA1 and ARMS2 polymorphisms in the response to intravitreal ranibizumab treatment for wet age-related macular degeneration in a Spanish population

Por Cruz-Gonzalez, Fernando, Cabrillo-Estevez, Lucia, Rivero-Gutierrez, Vanesa, Sanchez-Jara, Ana, De Juan-Marcos, Lourdes, Gonzalez-Sarmiento, Rogelio
Publicado no Int J Ophthalmol (2016)

Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity

Por Cobo, Manuel, Gutiérrez, Vanesa, Villatoro, Rosa, Trigo, Jose Manuel, Ramos, Inmaculada, López, Omar, Ruiz, María, Godoy, Ana, López, Irene, Arroyo, Macarena
Publicado no Lung Cancer (Auckl) (2017)

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain

Por Arriola, Edurne, García Gómez, Ramón, Diz, Pilar, Majem, Margarita, Martínez Aguillo, Maite, Valdivia, Javier, Paredes, Alfredo, Sánchez-Torres, José Miguel, Peralta Muñoz, Sergio, Barneto, Isidoro, Gutierrez, Vanesa, Andrade Santiago, Jesús Manuel, Aparisi, Francisco, Isla, Dolores, Ponce, Santiago, Vicente Baz, David, Artal, Angel, Amador, Mariluz, Provencio, Mariano
Publicado no BMC Cancer (2018)